Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery
Clinical trial NCT02493179 · UNKNOWN
Trial details
- NCT number
- NCT02493179
- Sponsor
- Hayat Pharmaceutical Co. PLC
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.